JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
BGLC Financials - Bionexus Gene Lab Income & Cash Flow | Ledgeburg
BGLC - Bionexus Gene Lab Corp.
USD | NASDAQ | Healthcare
Summary
Summary BGLC Stock
Financials
Financials BGLC Stock
Loading...
Loading...
Income Statement
Income Statement BGLC Stock
Balance Sheet
Balance Sheet BGLC Stock
Cash Flow Statement
Cash Flow Statement BGLC Stock
Loading...
Loading...
Home
Stocks
Bionexus Gene Lab Corp. (BGLC)
Financials
Financials of BGLC
Loading...
Loading...
Loading...
Loading...
Revenue
$7.424911M
Operating Income
$-2.965065M
Net Income
$-2.984607M
Share Count (Basic)
N/A
Operating Cash Flow
$-1.838382M
Free Cash Flow
$-1.875353M
Cash And Short-Term Equivalents
$2.486383M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
5M
10M
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
500K
1M
1.5M
2M
2.5M
Q1 FY25
Q2 FY25
Q3 FY25
Annual
Quarterly
Net Income $USD
-2M
0
2M
FY2021
Annual
Quarterly
Margins
Gross
Operating
Net
-40%
-20%
0%
20%
Q4 FY25
Q1 FY26
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-1M
-900K
-800K
-700K
-600K
-500K
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-2000%
-1500%
-1000%
-500%
0%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26